Go back to the newsletter archive

Abstract Submission

Presenting your research at ISHL11 is a powerful way to gain international recognition, valuable feedback from colleagues and to make important connections.

All abstracts will be published in a supplement of a high-quality journal and either selected for oral or poster presentation during ISHL11. A number of awards will be granted to high-quality abstracts during the opening ceremony of the congress.

The abstract submission will be open from February till May 2018. We will inform you in due time about the release of the submission system.

Might also be interesting

Scientific Program Highlights: Biomarkers

Treatment stratification by PET/CT has improved outcome and reduced treatment toxicity in Hodgkin Lymphoma. Recently, results of the GHSG HD18 trial were presented at EHA 2017. In this study…

Read more…


Developments in Advanced Stages

Latest Results of Large Scale Randomized Phase Ⅲ Trials in Advanced Stage HL

One central question in Hodgkin Lymphoma is the best treatment for advanced stage patients. Initial data of the company-sponsored international ECHELON-1 trial were expected with substantial interest and will be presented at ASH 2017 in detail…

Read more…